Induction of Myasthenia Gravis, Myositis, and Insulin-Dependent Diabetes Mellitus by High-Dose Interleukin-2 in a Patient With Renal Cell Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Induction of Myasthenia Gravis, Myositis, and Insulin-Dependent Diabetes Mellitus by High-Dose Interleukin-2 in a Patient With Renal Cell Cancer

Published:2002-07 Issue:4 Volume:25 Page:373-378
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:Journal of Immunotherapy

Author:

Fraenkel Paula G.,Rutkove Seward B.,Matheson Jean K.,Fowkes Mary,Cannon Marie E.,Patti Mary-Elizabeth,Atkins Michael B.,Gollob Jared A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference24 articles.

1. Interleukin-2 augments natural killer cell activity

2. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

3. A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

4. Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mouse IL-2/CD25 Fusion Protein Induces Regulatory T Cell Expansion and Immune Suppression in Preclinical Models of Systemic Lupus Erythematosus;The Journal of Immunology;2021-06-09

2. Endocrine Toxicities of Immunotherapy;Handbook of Cancer Treatment-Related Symptons and Toxicities;2020

3. Exazerbation einer okulären Myasthenia gravis;Der Ophthalmologe;2019-09-25

4. Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry;Journal for ImmunoTherapy of Cancer;2017-12

5. Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma;Journal for ImmunoTherapy of Cancer;2017-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3